Composite probiotics preparation for mitigating chemotherapy side effect

一种用于减轻化疗副作用的复合益生菌制剂

Abstract

A disclosed composite probiotics preparation for mitigating chemotherapy side effect is characterized in that the composite probiotics preparation is prepared by mixing the following probiotics according to certain live bacterium quantity: bifidobacterium breve, lactobacillus acidophilus, lactobacillus casei and streptococcus thermophilus with the ratio of 1:1-3: 1-3: 1-3, and the total live bacterium quantity of the mixed composite probiotics preparation is 20-80 billion. The composite probiotics preparation is capable of effectively mitigating patient side effect generated by chemotherapy.
本发明公开了一种用于减轻化疗副作用的复合益生菌制剂,其特征在于:所述的复合益生菌制剂由以下益生菌按照一定的活菌数量混合而成:短双歧杆菌∶嗜酸乳杆菌∶干酪乳杆菌∶嗜热链球菌=1∶1-3∶1-3∶1-3,且混合后的复合益生菌制剂的总活菌数量为200-800亿。这是一种能够有效减轻病人因化疗产生的副作用的复合益生菌制剂。

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (1)

    Publication numberPublication dateAssigneeTitle
    WO-03013558-A1February 20, 2003Simone Claudio DeTreatment of radiation-induced diarrhea with probiotics

NO-Patent Citations (2)

    Title
    P DELIA ET AL: "“Use of probiotics for prevention of radiation-induced diarrhea”", 《WORLD JOURNAL OF GASTROENTEROLOGY》
    吴英韬,等。: "“微生态制剂在肠内营养治疗的研究进展与应用”", 《中国微生态学杂志》

Cited By (1)

    Publication numberPublication dateAssigneeTitle
    CN-105394773-AMarch 16, 2016大连医科大学用于改善便秘的复合益生菌和膳食纤维制剂